• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ARROW FIBEROPTIX ULTRA 8 IAB: 8FR 30CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-05830-LWS
Medical Device Problem Code Gas/Air Leak (2946)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/03/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported "persistent helium loss 2 alarms".Additional information states that the iab catheter was removed and replaced.The second catheter was inserted into the same insertion site.No patient injury or consequence reported.The patient's current condition is reported as "fine".
 
Event or Problem Description
It was reported "persistent helium loss 2 alarms".Additional information states that the iab catheter was removed and replaced.The second catheter was inserted into the same insertion site.No patient injury or consequence reported.The patient's current condition is reported as "fine".
 
Additional Manufacturer Narrative
(b)(4).Returned for investigation was a 30cc 8.0fr fiberoptix ultra intra-aortic balloon catheter (iabc) with the original packaging label that matches the serial number of the returned sample.The sample was returned in the ups shipping box and was in a sealed bio-hazard bag.Upon return, the teflon sheath was noted on the iabc; liquid blood was noted within the sheath sidearm.The one-way valve was connected and tethered to the short driveline tubing.The iabc bladder was fully unwrapped.A bend to the iabc central lumen was noted at approximately 17cm from the iabc distal tip.Dried blood was noted on the exterior surfaces of the returned iabc.No blood was noted within the helium pathway.The fos connector and cal key were examined.The fos gray connector was properly seated in the blue clamshell housing and both retaining tabs were intact.The center post of the fos was centered.The blue clamshell housing was examined, and no abnormalities were noted.The cal key was intact.The cal key was examined, and no damage was noted.The customer submit-ted photo was reviewed.The photo shows the copy of the pump alarm strip with the "possible helium loss 2" alarm.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve, and it held for at least 1 minute and then 30 seconds five separate times according to quality system document.The cal key and fos were connected to the iabp.The cal key was recognized.The fos was connected and the iabp zeroed the iabc.The pump status displayed "ok" indicating the fiber is fully intact.The iabc central lumen was aspirated and flushed using a 60cc lab-inventory syringe.Some blood exited.The iabc was leak tested in accordance with testing methods from manufacturing procedure.An external leak was immediately detected from the bifurcate around the fos adhesive.Upon microscopic inspection, an external leak occurred from the fos adhesive bond at the bifurcate.No other leaks were detected.A lab inventory 0.025in guidewire was back loaded through the iabc distal tip.Resistance was noted at approximately 17.1cm from the iabc distal tip, which is the location of the previously noted bend.The guidewire was able to advance through the central lumen.Some blood noted on the guidewire.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.The reported complaint for "persistent helium loss 2 alarms" is confirmed.During the investigation, an external helium leak was confirmed from the iabc bifurcate fos adhesive.Based on a review of the device history record (dhr), the product met specification upon release; however, the specifications were not met during the complaint investigation due to the leak at the bifurcate fos adhesive.The probable root cause of the bifurcate fos adhesive leak is manufacturing related.A corrective and preventive action (capa) has been initiated to further investigate the issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW FIBEROPTIX ULTRA 8 IAB: 8FR 30CC
Common Device Name
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
sachin sony
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key21469485
Report Number3010532612-2025-00136
Device Sequence Number3410483
Product Code DSP
UDI-Device Identifier00801902034724
UDI-Public(01)00801902034724(11)240717(17)260630(10)18F24G0018(21)
Combination Product (Y/N)N
Initial Reporter StateHI
Initial Reporter CountryUS
PMA/510(K) Number
K021462
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 02/03/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date06/30/2026
Device Catalogue NumberIAB-05830-LWS
Device Lot Number18F24G0018
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/17/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/03/2025
Supplement Date Received by Manufacturer03/07/2025
Initial Report FDA Received Date02/26/2025
Supplement Report FDA Received Date03/18/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/17/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
N/A.; N/A.
Patient SexFemale
-
-